Additionally, multiple studies indicated that cDC1 are crucial to mount productive anti-tumor immune responses including responses following therapeutic checkpoint inhibitor or chemotherapy treatment regimens [39,576,613,617,618,619,620]. Here, MPPE1 is linked to neoplasm.